An inhaler alone will not treat pneumonia, and for most people without an underlying lung condition, it offers little meaningful relief. Pneumonia is an infection deep in the air sacs of the lungs, not primarily a problem of narrowed airways, which is what inhalers are designed to open. That said, there are specific situations where an inhaler can play a supporting role alongside the antibiotics or antivirals that actually fight the infection.
Why Inhalers Have Limited Effect on Pneumonia
Rescue inhalers like albuterol work by relaxing the muscles around your airways, making it easier for air to flow in and out. This is effective when the core problem is airway constriction, as in asthma or COPD flare-ups. Pneumonia works differently. The infection inflames and fills the tiny air sacs (alveoli) deep in the lungs with fluid and pus. That fluid buildup is what makes breathing difficult, and opening the airways wider doesn’t clear it out.
A study of hospitalized pneumonia patients found that inhaled bronchodilators did not improve clinical outcomes or reduce mortality. The researchers noted this is likely because the infection primarily affects the lung tissue itself and the blood vessels surrounding it, not the airways. Over 80% of the patients in that study needed supplemental oxygen, which underscores that the breathing difficulty in pneumonia comes from impaired gas exchange deep in the lungs rather than from airway tightness.
When an Inhaler Actually Helps
The exception is when pneumonia triggers wheezing or bronchospasm on top of the infection. This is more common in certain groups:
- People with asthma or COPD. If you already have a condition that narrows your airways, pneumonia can worsen that narrowing. Continuing your prescribed inhaler during a bout of pneumonia is important for managing the airway component of your symptoms. Clinical guidelines recommend bronchodilator therapy for patients with these conditions, and there’s no evidence that using one increases your risk of making the pneumonia worse.
- Patients with audible wheezing. Pneumonia sometimes causes enough airway inflammation to produce wheezing even in people without a chronic lung disease. In these cases, a doctor may prescribe a short-acting bronchodilator to ease that specific symptom. Albuterol is FDA-approved for acute bronchospasm in reversible obstructive airway disease, and doctors use clinical indicators like continuous wheezing and the patient’s history to decide whether it’s appropriate.
- Children with reactive airways. Young children who wheeze with respiratory infections are frequently given albuterol in emergency departments. Pediatric physicians typically base that decision on the child’s age, whether they have a history of allergic conditions, and the pattern of wheezing.
If you don’t fall into one of these categories and you’re using a friend’s or family member’s inhaler hoping it will ease your pneumonia symptoms, it’s unlikely to make a noticeable difference.
A Caution About Steroid Inhalers
Inhaled corticosteroids, the type used as daily maintenance therapy for asthma and COPD, deserve separate mention. These reduce inflammation in the airways over time, but in COPD patients they have been linked to a higher risk of developing pneumonia in the first place. Clinical trials found that certain inhaled steroids increased pneumonia risk by 64% to 94% at higher doses, with even lower doses roughly doubling the incidence over a year. The risk appears to vary by the specific medication: fluticasone carries a higher risk, while budesonide has shown little to no increased pneumonia risk in pooled analyses of several thousand patients.
This doesn’t mean you should stop your prescribed steroid inhaler if you get pneumonia. Abruptly stopping can cause its own problems. But it’s worth knowing that steroid inhalers are not a treatment for pneumonia and, in certain populations, may have contributed to the conditions that led to the infection.
What Actually Treats Pneumonia
Pneumonia requires treatment directed at the infection itself. Bacterial pneumonia is treated with antibiotics. Viral pneumonia may be treated with antivirals in some cases, or managed with supportive care while the immune system clears the virus. The key interventions that improve breathing during pneumonia are supplemental oxygen (when blood oxygen levels drop), fluids to prevent dehydration, and rest.
Recovery timelines vary widely. Some people feel better and return to normal routines within one to two weeks, while others take a month or longer. Most people continue to feel tired for about a month even after the acute infection has cleared. During this recovery period, lingering cough and mild shortness of breath are common, and these are generally signs of healing lung tissue rather than a signal that you need a bronchodilator.
Nebulizer vs. Inhaler for Lung Symptoms
If your doctor does prescribe a bronchodilator for wheezing during pneumonia, you might wonder whether a nebulizer (the machine that creates a fine mist you breathe through a mask) works better than a standard handheld inhaler. Research shows that a metered-dose inhaler used with a spacer is equally effective as a nebulizer for delivering the same medication. Both patients and healthcare providers tend to perceive nebulizers as more effective, but clinical outcomes are comparable. In practice, the choice often comes down to what’s available and whether you can coordinate the inhaler technique while feeling unwell.
The Bottom Line on Inhalers and Pneumonia
If you’re dealing with pneumonia and wondering whether grabbing an inhaler will help you breathe easier, the answer depends entirely on whether airway narrowing is part of your symptom picture. For the majority of pneumonia cases, the problem is fluid in the lungs, not tight airways, and an inhaler won’t address that. If you have asthma, COPD, or noticeable wheezing alongside pneumonia, a bronchodilator can relieve that specific layer of discomfort while antibiotics or antivirals do the heavy lifting against the infection itself.